Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on BISBI. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Grignard route for bidentate phosphine ligands avoids n-butyllithium, offering safer, scalable manufacturing for hydroformylation catalysts.
Novel bisbibenzyl synthesis route offering cost-effective anti-inflammatory and antitumor intermediates with scalable production capabilities for global pharma supply chains.